Sign In to Follow Application
View All Documents & Correspondence

“Process For The Synthesis Of 7 Chloro 1,2,3,4 Tetrahydro 2 Methyl 3 (2 Melhylphenyl) 4 Oxo 6 Quinazolinesulfona Mide(metolazone)”

Abstract: The present invention describes an improved process for the preparation of substantially pure 7-chloro-l,2,3,4-tetrahydro-2-methyl-3-(2-melhylphenyl)-4-oxo-6-quinazolinesulfonamide (Metolazone) (1).

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
12 July 2018
Publication Number
03/2020
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
radha@biophore.com
Parent Application
Patent Number
Legal Status
Grant Date
2024-02-21
Renewal Date

Applicants

Biophore India pharmaceuticals Pvt. Ltd
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.

Inventors

1. Manik Reddy Pullagurla
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.
2. Jagadeesh Babu Rangisetty
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.

Specification

1. An improved process for the preparation of Metolazone (1)
W
comprising:
a) oxidizing N-(5-chloro-2-methyl-4-suIfamoyIphenyl) acetamide (5)
l
in presence of a suitable oxidizing agent and base to form 2-acetamido-4-chloro-5-sulfamoylbenzoic acid (4);
b) condensing intermediate (4) with O-toluidine (3)
in presence of a suitable carboxyl activating agent to form 7-chloro-2-methyl-4-oxo-3-o-tolyl-3,4-dihydroquinazoline-6-sulfonamide (2);

c) reducing intermediate (2) using a suitable reducing agent to obtain 7-chloro-2-methyI-4-oxo-3-o-tolyI-l,2,3,4-tetrahydroquinazoIine-6-sulfonamide (Metolazone) (1); and
d) purifying Metolazone (1) from suitable solvents.

2. The process according to claim 1, wherein the oxidizing agent is selected from a group comprising of potassium permanganate, potassium dichromate, potassium nitrate.
3. The process according to claim 1, wherein the base used in step a) may be selected from a group comprising triethyl amine, diisopropylethylamine, diethyl amine, isopropyl amine, morpholine, N-methyl morpholine, pyridine, ammonia, potassium tertiary butoxide, potassium ethoxide, sodium methoxide, lithium tertiary butoxide, , lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, cesium hydroxide , sodium carbonate, potassium carbonate, magnesium carbonate, sodium bicarbonate, potassium bicarbonate or mixtures thereof.
4. The process according to claim 1, wherein the carboxyl activating agents used in step b) is selected from a group comprising of phosphorus trichloride, phosphorous pentachloride, thionyl chloride, t-butyloxycarbonyl hydrazide or mixtures thereof.
5. The process according to claim 1, wherein the reducing agents used in step c) is selected from a group comprising of sodium borohydride, lithium aluminium hydride, diisobutyl aluminium hydride (DIBAL), lithium triethyl borohydride or mixtures thereof.

6. A process for the purification of Metolazone (1) comprising of:
1. providing a solution of Metolazone (1) in a suitable aprotic solvent;
2. filtering the reaction mixture through micron filter;
3. removing the solvent under vacuum;
4. adding suitable protic solvent to the solid;
5. heating the reaction mixture; and
6. isolating Metolazone (1).

8. The process according to claim 6, wherein the solvent is selected from a group comprising of acetone, acetonitrile, ethyl acetate, dichloromethane, methyl tertiary butyl ether, water, methanol, ethanol, n-propanol, n-butanol t-butanol, isopropyl alcohol or mixtures thereof.
9. The process according to claim 1, wherein the intermediate (5) is prepared comprising:

a) Acetylation of 5-chloro-2-methylalinine (8) to form N-(5-chloro-2-methyl phenyl) acetamide (7);
b) sulphonation of intermediate (7) to form 4-acetamido-2-chloro-5-methylbenzene-1-sulfonyl chloride (6) in presence of a suitable sulphonating agent; and
c) amination of intermediate (6) in presence of aqueous ammonium hydroxide to form N-(5-chloro-2-methyl -4-sulfamoylphenyl) acetamide (5).
10. The process according to claim 9, wherein the suitable sulfonating agent used
in the present invention is selected from a group comprising of chlorosulfuric
acid, sulphuric acid, sulphonic acid and oleum.

Documents

Application Documents

# Name Date
1 201841026037-PROVISIONAL SPECIFICATION [12-07-2018(online)].pdf 2018-07-12
2 201841026037-FORM 1 [12-07-2018(online)].pdf 2018-07-12
3 201841026037-DRAWINGS [12-07-2018(online)].pdf 2018-07-12
4 Correspondence by Applicant_New Filing Receipt_01-08-2018.pdf 2018-08-01
5 201841026037-FORM 3 [11-07-2019(online)].pdf 2019-07-11
6 201841026037-ENDORSEMENT BY INVENTORS [11-07-2019(online)].pdf 2019-07-11
7 201841026037-COMPLETE SPECIFICATION [11-07-2019(online)].pdf 2019-07-11
8 Correspondence by Agent _Submission Of Document_15-07-2019.pdf 2019-07-15
9 201841026037-FORM 18 [05-07-2022(online)].pdf 2022-07-05
10 201841026037-FER.pdf 2022-07-13
11 201841026037-FER_SER_REPLY [13-01-2023(online)].pdf 2023-01-13
12 201841026037-CORRESPONDENCE [13-01-2023(online)].pdf 2023-01-13
13 201841026037-CLAIMS [13-01-2023(online)].pdf 2023-01-13
14 201841026037-ABSTRACT [13-01-2023(online)].pdf 2023-01-13
15 201841026037-US(14)-HearingNotice-(HearingDate-30-01-2024).pdf 2023-12-18
16 201841026037-Correspondence to notify the Controller [27-01-2024(online)].pdf 2024-01-27
17 201841026037-Written submissions and relevant documents [13-02-2024(online)].pdf 2024-02-13
18 201841026037-PatentCertificate21-02-2024.pdf 2024-02-21
19 201841026037-IntimationOfGrant21-02-2024.pdf 2024-02-21

Search Strategy

1 SearchstrategyE_12-07-2022.pdf

ERegister / Renewals

3rd: 15 May 2024

From 12/07/2020 - To 12/07/2021

4th: 15 May 2024

From 12/07/2021 - To 12/07/2022

5th: 15 May 2024

From 12/07/2022 - To 12/07/2023

6th: 15 May 2024

From 12/07/2023 - To 12/07/2024

7th: 15 May 2024

From 12/07/2024 - To 12/07/2025